| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.03. | Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis | 459 | Business Wire | Nemolizumab is a first-in-class investigational monoclonal antibody designed to provide relief from itch by targeting IL-31
One-year data from an interim analysis of the OLYMPIA long-term... ► Artikel lesen | |
| 10.03. | Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis | 561 | Business Wire | Randomized Phase 2 study met its primary and secondary endpoints following 16 weeks of treatment across all dosing groups, reinforcing povorcitinib's potential role in treating prurigo nodularis... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 5.162 |
| EVOTEC | 2.311 |
| SUPER MICRO COMPUTER | 2.280 |
| BAYER | 2.157 |
| NEL | 2.147 |
| MICROSTRATEGY | 1.839 |
| RHEINMETALL | 1.164 |
| TUI | 918 |
| TESLA | 867 |
| PORSCHE AG | 776 |
| COINBASE GLOBAL | 766 |
| SNOWFLAKE | 738 |
| PALANTIR TECHNOLOGIES | 715 |
| VOLKSWAGEN | 625 |
| ALPHABET | 603 |
| AMAZON | 587 |
| THYSSENKRUPP | 584 |
| RENK GROUP | 582 |
| GAMESTOP | 530 |
| MERCEDES-BENZ | 527 |
| BIONTECH | 517 |
| AIXTRON SE | 511 |
| BITCOIN GROUP SE | 473 |
| BYD | 462 |
| BASF | 455 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
